Skip to main content

Table 3 Base Case: Lifetime Results for the 50+ Age Group

From: A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK

Results

Lifetime horizon

TPP

Societal

ICERs

Cost per QALY

£13,077

£11,417

 

Cost per HZ Case Avoided

£1,440

£1,258

 

Cost per PHN Case Avoided (1 month def)

£5,421

£4,733

 

Cost per PHN Case Avoided (3 month def)

£5,453

£4,761